Literature DB >> 13150193

Acute myocardial infarction; a discussion of certain controversial issues.

H B BURCHELL.   

Abstract

As a general rule, it is not believed possible to classify patients with acute myocardial infarction as to the future severity of their illness at the time of the initial examination. However, classifications are possible from complete clinical data of the first few days with regard to the predicted mortality rates. Whether to manage the patient in the hospital or at home depends on the community facilities. The patient should be in bed for a period of two to three weeks if unquestioned infarction has occurred. The main avenue of investigation as to lowering of mortality needs to be directed toward the prevention of heart failure or sudden unexpected death probably related to arrhythmia. If the patient is hospitalized and laboratory facilities are available, anticoagulant therapy can be safely and effectively carried out without undue risk or prohibitive increase in the cost of management. The experience of the author and his colleagues has led to the belief that anticoagulants given routinely to patients with myocardial infarction are effective in decreasing the incidence of thromboembolic complications.

Entities:  

Keywords:  MYOCARDIAL INFARCT/therapy

Mesh:

Year:  1954        PMID: 13150193      PMCID: PMC1531975     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  13 in total

1.  Myocardial infarction and its treatment with anticoagulants: a summary of the findings for 1031 cases.

Authors:  I S WRIGHT; D F BECK; C D MARPLE
Journal:  Mod Concepts Cardiovasc Dis       Date:  1954-01

2.  Anticoagulant therapy in acute myocardial infarction.

Authors:  H I RUSSEK; B L ZOHMAN
Journal:  Am J Med       Date:  1953-06       Impact factor: 4.965

3.  Mortality and other studies questioning the evidence for and value of routine anticoagulant therapy in acute myocardial infarction.

Authors:  S SCHNUR
Journal:  Circulation       Date:  1953-06       Impact factor: 29.690

4.  Cardiac aneurysms; clinicopathologic studies.

Authors:  W S PHARES; J E EDWARDS; H B BURCHELL
Journal:  Proc Staff Meet Mayo Clin       Date:  1953-05-06

5.  Hemopericardium complicating myocardial infarction in the absence of cardiac rupture; report of three cases.

Authors:  M W ANDERSON; N A CHRISTENSEN; J E EDWARDS
Journal:  AMA Arch Intern Med       Date:  1952-11

6.  Anticoagulant therapy in acute myocardial infarction; a survey of specialists' opinions concerning indications, results and dangers.

Authors:  H I RUSSEK; B L ZOHMAN
Journal:  Am J Med Sci       Date:  1953-01       Impact factor: 2.378

7.  A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association.

Authors:  L A SCARRONE; D F BECK; I S WRIGHT
Journal:  Circulation       Date:  1952-10       Impact factor: 29.690

8.  "Armchair" treatment of acute coronary thrombosis.

Authors:  S A LEVINE; B LOWN
Journal:  J Am Med Assoc       Date:  1952-04-19

9.  Myocardial infarction with and without acute coronary occlusion; a pathologic study.

Authors:  R D MILLER; H B BURCHELL; J E EDWARDS
Journal:  AMA Arch Intern Med       Date:  1951-11

10.  Anticoagulants in coronary thrombosis with myocardial infarction.

Authors:  D A RYTAND
Journal:  AMA Arch Intern Med       Date:  1951-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.